BARCLAYS PLC - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 163 filers reported holding ASSERTIO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$14,000
-83.3%
21,485
-67.6%
0.00%
Q4 2019$84,000
-64.7%
66,250
-64.2%
0.00%
Q3 2019$238,000
-67.5%
185,031
-12.9%
0.00%
Q2 2019$732,000
+88.2%
212,355
+175.8%
0.00%
Q1 2019$389,000
+146.2%
77,002
+76.0%
0.00%
Q4 2018$158,000
-72.2%
43,754
-54.7%
0.00%
Q3 2018$568,00096,5470.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Senvest Management, LLC 5,006,637$29,439,0002.23%
ARMISTICE CAPITAL, LLC 3,000,000$17,640,0001.06%
DELTEC ASSET MANAGEMENT LLC 517,606$3,044,0000.58%
PERKINS CAPITAL MANAGEMENT INC 125,550$738,0000.44%
Matarin Capital Management, LLC 600,223$3,529,311,0000.23%
GLOBEFLEX CAPITAL L P 196,615$1,156,0000.23%
ALGERT GLOBAL LLC 139,129$818,0000.18%
TSP Capital Management Group, LLC 53,575$315,0000.16%
CORNERCAP INVESTMENT COUNSEL INC 157,235$925,0000.12%
Connor, Clark & Lunn Investment Management Ltd. 3,060,189$17,994,0000.10%
View complete list of ASSERTIO THERAPEUTICS INC shareholders